Shouxiangu\'s announcement on the “Shoushou 22 Convertible Bonds” share conversion results and share changes
Shouxianggu: Shouxianggu\'s announcement on the signing of a major contract for daily operation by a wholly-owned subsidiary
Shouxiangoku\'s announcement on the signing of a major contract for daily operation by a wholly-owned subsidiary
Shouxiangu\'s announcement on the completion of domestic health food filing by its wholly-owned subsidiary
Shouxianggu: Shouxianggu\'s announcement on the completion of the registration of industrial and commercial changes
Shouxianggu\'s announcement on completing the registration of industrial and commercial changes
Shusengoku Company Articles of Association (revised in September 2024)
Status of the 2024 Investor Reception Day event in Shouxianggu
Shouxiangu Supplementary Announcement on Cancelling the Repurchase of Shares, Reducing Registered Capital and Notifying Creditors
Announcement of Zhejiang Shouxiangu Pharmaceutical and its wholly-owned subsidiary obtaining invention patent certificates.
Legal Opinion from Zhejiang Tiance Law Firm regarding the 2024 First Extraordinary Shareholders' Meeting of Zhejiang Shouxiangu Pharmaceutical
Announcement from Zhejiang Shouxiangu Pharmaceutical regarding the appointment of members to the fourth board of directors' special committee.
Notice of Resolutions of the First Extraordinary Shareholders' Meeting of Zhejiang Shouxiangu Pharmaceutical in 2024.
Announcement from Zhejiang Shouxiangu Pharmaceutical on not downwardly revising the conversion price of Shou 22 Convertible Bonds.
Announcement of Zhejiang Shouxiangu Pharmaceutical's establishment of a cash management settlement account for raising funds by its wholly-owned subsidiary and signing a four-party supervision agreement for raising funds.
Zhejiang Shouxiangu Pharmaceutical's informative announcement regarding the expected downward revision of the conversion price for Shou 22 convertible bonds.
Zhejiang Shouxiangu Pharmaceutical's material for the first extraordinary shareholders' meeting in 2024.
Notice of Zhejiang Shouxiangu Pharmaceutical calling for the first extraordinary general meeting of shareholders in 2024.
Zhejiang Shouxiangu Pharmaceutical Articles of Association (revised in July 2024).
Shouxiangu's announcement on changing the company's business scope and revising the “Articles of Association”
No Data
No Data